Please complete the CAPTCHA to continue
@poseida.com
✓
4 phones found area 727, 312, and 888
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Brent Warner is listed as CEO and Board Member at Protego Biopharma, based in San Diego, California, United States. AeroLeads shows a work email signal at poseida.com, phone signal with area code 727, 312, 888, and a matched LinkedIn profile for Brent Warner.
Brent Warner previously worked as Chief Executive Officer, Board Member at Protego Biopharma and Board Member at Cure Rare Disease. Brent Warner holds Bachelor Of Business Administration, Business Management, Management Information Systems from Northwood University.
This section adds company-level context without repeating Brent Warner's masked contact details.
AeroLeads found 1 current-domain work email signal for Brent Warner. Compare company email patterns before reaching out.
Brent Warner serves as CEO of Protego Biopharma with over 15 years of biopharmaceutical experience across rare diseases, gene therapy and other therapeutic categories.Mr. Warner was previously President of Gene Therapy at Poseida Therapeutics (NASDAQ: PSTX) leading advancements across genetic diseases, and overseeing research / pre-clinical development of non-viral gene therapy programs and platform technologies (piggyBac DNA insertion system, nanoparticles, Cas-CLOVER gene editing).Mr. Warner joined Poseida as President, Gene Therapy in February 2022, bringing over 15 years of biopharmaceutical experience across rare diseases, gene therapy and other therapeutic categories. Most recently with Novartis as Vice President, Gene Therapy and Rare Disease, he was responsible for building a division to commercialize multiple rare disease therapies, having led the successful launches of ZOLGENSMA and LUXTURNA. His prior roles include serving as a U.S. commercial leader in Hemophilia A at BioMarin Pharmaceuticals working on efforts to advance ROCTAVIAN. He held a variety of strategic and operational U.S. and ex-U.S. roles at Biogen with the predominate focus on launching SPINRAZA in multiple countries, and in commercial launch roles across Hematology, Immunology, Oncology, and Medical Devices at Baxalta, now a wholly owned subsidiary of Takeda. Prior to those roles, Mr. Warner held several strategic roles in consulting organizations and a global lead role within a consumer goods company. Mr. Warner has an MBA with an emphasis in marketing and finance and a Bachelor of Business Administration degree, both from Northwood University in Michigan. Mr. Warner serves on the board of Cure Rare Disease, a non-profit organization focused on enabling the development of life-saving genetic medicines for rare and ultra-rare patient populations.
Listed skills include Integrated Marketing, Email Marketing, Marketing Strategy, Marketing, and 30 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
San Diego, California, Us
Protego focuses on the discovery and development of first-in-class small-molecule therapeutics that aim to reprogram protein folding for the treatment of various diseases. We are exploring monogenetic protein misfolding diseases that cause myopathy, cardiomyopathy, stroke, renal disease, retinal diseases, channelopathies, and various degenerative diseases.
Boston, Massachusetts, Us
Cure Rare Disease is developing custom therapeutics that are as unique to the individuals they are meant to treat. Our mission is to offer effective, life-saving treatments developed through collaborations with world-renowned researchers and clinicians, and in partnership with our generous donors. Our customized therapeutics are designed specifically for the men and women who continue to fight for their right to live long, full, healthy lives despite having been diagnosed with a rare genetic disorder for which they’ve been told there is no treatment or cure.
San Diego, California, Us
President and Head of Gene Therapy with a focus on advancing pre-clinical Gene Therapy programs to clinical stage, and overseeing development of non-viral gene therapy programs and platform technologies (piggyBac DNA insertion system, nanoparticles, Cas-CLOVER gene editing).
Basel, Baselstadt, Ch
Head of rare disease with overall responsibility for ZOLGENSMA, LUXTURNA, and ILARIS.Responsible for three different therapeutic areas, reporting to the Head of Pharma and a member of the local Pharmaceutical Executive team (PEC).
Cambridge, Ma, Us
US leader responsible for strategic projects/operations and US commercialization of BIIB092 for Progressive Supranuclear Palsy (PSP).
Cambridge, Ma, Us
Country head of Rare Disease responsible for enabling access to SPINRAZA in Canada.
Cambridge, Ma, Us
US strategic leader responsible for the US strategy and execution of SPINRAZA.
Cambridge, Ma, Us
EU brand leader working to guide launch of SPINRAZA across Europe.
Cambridge, Ma, Us
Global brand leader responsible for the global strategy and execution of SPINRAZA.
San Rafael, Ca, Us
US leader responsible for commercialization of ROCTAVIAN (BMN270) - Gene Therapy, Hemophilia.
Illinois, Us
Global strategy team working on advancing therapies to treat von Willebrand's disease and Sickle Cell Disease.
Illinois, Us
Global head of early stage/launch assets and marketing across Hematology, Immunology, Oncology and Medical Devices.
Illinois, Us
Rotational program to support country launches of HyQvia, BaxJect III, and Obizur.
Clearwater, Fl, Us
Global marketing head responsible for strategy, operations, communications/PR across 143 markets worldwide.
Various roles supporting portfolio strategies across Pharma, launch strategy and execution.
Quick answers generated from the profile data available on this page.
Brent Warner works for Protego Biopharma.
Brent Warner is listed as CEO and Board Member at Protego Biopharma.
AeroLeads has found 1 work email signal at @poseida.com for Brent Warner at Protego Biopharma.
AeroLeads has found 4 phone signal(s) with area code 727, 312, 888 for Brent Warner at Protego Biopharma.
Brent Warner is based in San Diego, California, United States while working with Protego Biopharma.
Brent Warner has worked for Protego Biopharma, Cure Rare Disease, Poseida Therapeutics, Inc., Novartis, and Biogen.
You can use AeroLeads to view verified contact signals for Brent Warner at Protego Biopharma, including work email, phone, and LinkedIn data when available.
Brent Warner holds Bachelor Of Business Administration, Business Management, Management Information Systems from Northwood University.
Brent Warner is listed with skills including Integrated Marketing, Email Marketing, Marketing Strategy, Marketing, Advertising, E Commerce, Strategic Planning, and Cross Functional Team Leadership.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts